Panacea Biotec donates 125,000 doses of Easyfive-TT to Cuba

This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba

0
39
New Delhi: Panacea Biotec on humanitarian grounds has donated 125,000 single dose vials (SDVs) of its WHO Prequalified Pentavalent vaccine, Easyfive-TT, to the Ministry of Health of Republic of Cuba for use in Cuba National Health System specifically in the expanded immunization program due to current ongoing shortage of the wP based Pentavalent Vaccine in Cuba.
Speaking on the occasion, Dr. Rajesh Jain, Chairman & Managing Director, Panacea Biotec said, “Panacea Biotec believes in giving a chance for Better health. The government has time and again emphasized “Vasudhaiva Kutumbakam” meaning the “World is one Family”. Our donation is a small step in our continuous strive for Indian science and capabilities for the benefit of all.”
Alejandro Simancas Marin, Ambassador, Republic of Cuba said, “By virtue of the above, the Embassy of the Republic of Cuba on behalf of the government and the Cuban people wishes to express its deep gratitude to Panacea Biotec, its managements and specialists for his gesture of solidarity. Without a doubt, this donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba and that it covers free of charge to all the children of Cuba.”
Panacea Biotec and the Cuban institutions in the biopharmaceutical industry maintain a working and collaborative relationship that goes beyond commercial interests and has resulted in mutual benefit and has highlighted the opportunities and potential that exists in this sector for bilateral collaboration.
Paediatric vaccination plays an important role to achieve Sustainable Development Goals (SDGs) set by the United Nations, in particular the target to reduce under-five mortality rate to less than 25 per 1000 live births.
We have been privileged to partner with the Center for Genetic Engineering & Biotechnology for over 20 years and provide sustainable supplies of our vaccines globally to enable people to live healthier and live longer. We are happy to support our friends in their time of need and we continue to fight and minimise the impact of the Covid-19 pandemic.